top of page

Pro Pharmaceuticals Group Celebrates 10th CPHI at Milan 2026

5 days ago
2 min read

From Madrid in 2015 to Milan in 2026 — a decade of building international relationships in the pharmaceutical industry.


Pro Pharmaceuticals Group has returned from CPHI Milan 2026, marking an important milestone for our business — our 10th CPHI.


Our Managing Director, Sandip Manku, first attended CPHI in Madrid in 2015, the same year he founded Pro Pharmaceuticals Group in Melbourne, Australia.


What started as a small Australian pharmaceutical sourcing business has developed into an international operation, working with pharmaceutical manufacturers, wholesalers, clinical research organisations and healthcare providers across multiple markets.

Over the past decade, CPHI has played an important role in that journey.


Building relationships across the pharmaceutical industry


One of the most valuable aspects of attending CPHI each year is the opportunity to meet face-to-face with our international partners, many of whom we have worked with for several years.


The pharmaceutical industry continues to evolve, but strong relationships, trust and reliable supply remain as important as ever.


This year's event in Milan provided an opportunity for Sandip and Lukasz Nowaczek, who leads our European clinical trial activities, to reconnect with existing partners and meet new companies interested in working with Pro Pharmaceuticals Group.


Discussions covered pharmaceutical sourcing, unlicensed medicines, comparator and reference listed drugs, clinical trial supply and potential new opportunities for the Australian market.


Looking ahead


As Pro Pharmaceuticals Group continues to expand its international network, events such as CPHI remain an important part of our business development.


Reflecting on the milestone, Sandip commented:


"It's hard to believe it's been 10 CPHIs since my first visit to Madrid in 2015. A lot has changed in our business over that time, but what I still enjoy most is catching up with people we've known for years, meeting new people and exploring opportunities. It's also a chance to step away from the day-to-day business and think about where we go next."


We would like to thank everyone who took the time to meet with us in Milan.


We look forward to continuing those conversations and building on the relationships established over the past decade.


About Pro Pharmaceuticals Group


Pro Pharmaceuticals Group is an Australian-based pharmaceutical sourcing and supply company specialising in unlicensed medicines, Section 19A supply, comparator and reference listed drug sourcing, and clinical trial supply.


Working with an international network of suppliers and partners, we help healthcare providers and pharmaceutical companies access medicines for patients and clinical research.



Recent Posts
Archive
Search By Tags
Follow Us
  • Twitter Social Icon
  • Google+ Basic Square

Legal & Trademark Notice
© 2026 Pro Pharmaceuticals Group Pty Ltd. All rights reserved.
Pro PG, CheckMed, and their respective logos are registered trademarks owned worldwide by Pro Pharmaceuticals Group Pty Ltd.
Pro Pharmaceuticals Group operates globally through associated entities, including CTS Pharmaceuticals Pty Ltd (Australia), Jemstar Sp. z o.o. (Poland), and Pro Pharmaceuticals Group NZ Ltd (New Zealand).

International Tax Registrations:
ABN 20 605 457 430 (Australia) | VAT DE401757398 (EU VAT ID) | Steuernummer 15/460/00493 (Germany) | VAT PL5263362401 (Poland) | VAT NL825524295B01 (Netherlands).

bottom of page